Regulatory Series No.1 - Clinical Evaluation Requirements

White Paper


This paper outlines the differences between MEDDEV 2.7/1 revision 4 and MDR 2017/745 regarding clinical evaluation, the potential deficiencies for approved products that must transition and any associated actions to take as a legal manufacturer.

Have the white paper sent to you:



Previous Post Next Post